GlassScriptPhysician profile
Frederick J Gahl
NPI 1760443774
$11,741.97
in general payments reported to CMS, 2019-2025
44 companies · $2,298 in 2025
The $2,298 reported for 2025 was more than what 85% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,189 · 2020: $966 · 2021: $1,819 · 2022: $1,938 · 2023: $1,528 · 2024: $2,003 · 2025: $2,298.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,829.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,591.34 | 2021-2025 | |
| Nevro Corp. | $1,465.30 | 2019-2024 | Senza |
| Collegium Pharmaceutical, INC. | $1,179.80 | 2019-2025 | Belbuca, Xtampza, Nucynta |
| Biotronik Nro, INC. | $930.24 | 2023-2025 | Prospera, Biotronik |
| Abbott Laboratories | $919.08 | 2019-2025 | Eterna, Proclaim, Ionicrf |
| Amgen INC. | $895.31 | 2020-2024 | Evenity, Prolia |
| Boston Scientific Corporation | $649.20 | 2019-2025 | General - Pain Management |
| Pfizer INC. | $369.67 | 2019-2025 | |
| Biohaven Pharmaceutical Holding Company LTD. | $355.74 | 2022 | |
| Biodelivery Sciences International, INC. | $346.20 | 2019-2021 | |
| Globus Medical, INC. | $320.87 | 2025 | Senza |
| Fidia Pharma USA INC. | $278.03 | 2020-2025 | Hymovis, Triluron, Hyalgan |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $268.78 | 2020-2025 | Relistor |
| Avanos Medical | $209.98 | 2021-2024 | Trivisc Sodium Hyaluronate, Genvisc 850 Sodium Hyaluronate, Generator |
| Biohaven Pharmaceuticals, INC. | $186.54 | 2020-2021 |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $169.26 | 2020 | |
| Almatica Pharma LLC | $154.24 | 2021-2023 | Gralise |
| Saluda Medical Americas, INC. | $152.84 | 2022-2025 | Evoke |
| Trevena, INC. | $128.69 | 2022-2023 | Olinvyk |
| Impel Pharmaceuticals INC. | $122.93 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $113.72 | 2019-2021 | |
| Tersera Therapeutics LLC | $102.99 | 2019 | |
| Depuy Synthes Sales INC. | $86.71 | 2019-2023 | Monovisc, Orthovisc |
| Si-Bone, INC. | $79.71 | 2019-2025 | |
| Pacira Therapeutics, INC. | $65.97 | 2019-2021 | |
| Pacira Pharmaceuticals Incorporated | $61.76 | 2025 | Zilretta, Iovera |
| Scilex Pharmaceuticals INC. | $56.54 | 2024-2025 | |
| Daiichi Sankyo INC. | $48.42 | 2019 | |
| Valinor Pharma, LLC | $48.26 | 2025 | Movantik |
| Lundbeck LLC | $41.65 | 2022-2023 | Vyepti |
| Vertex Pharmaceuticals Incorporated | $40.95 | 2024-2025 | |
| Stryker Corporation | $38.16 | 2020 | |
| Lilly USA, LLC | $37.01 | 2022 | |
| Shionogi INC | $29.31 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $28.59 | 2023 | Seglentis |
| Averitas Pharma INC. | $26.28 | 2025 | Qutenza |
| Spinal Simplicity, LLC | $24.68 | 2023 | Ha Minuteman G3-R |
| Nalu Medical, INC. | $22.58 | 2022 | |
| Medtronic, INC. | $17.91 | 2021 | |
| Curonix LLC | $16.57 | 2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Relievant Medsystems, INC. | $16.32 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.20 | 2019 | |
| Vibrant Gastro, INC. | $15.82 | 2024 | Vibrant Starter Kit |
| Athena Bioscience, LLC | $11.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Gahl listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.